BioStock published an article on 30 March 2021 about Follicum, which can be read in full below. Follicum, a company that develops tissue repair peptides, has advanced further in its preclinical work with developing a drug candidate for the treatment of diabetes. Through extensive and advanced experimental work, the company believes that the peptides bind […]
Presentation BioStock Life Science Summit 2020, November 18
Our drug candidate FOL-005 has demonstrated increased hair growth on both healthy individuals and on patients with alopecia in two clinical phase II trials, which both demonstrated good safety and efficacy.
Read moreFollicum AB announces today that the company has recruited Dr. Kim Arvid Nielsen as new CEO, taking...
Follicum AB today announces that significant progress has been made in the company’s developme...
Follicum AB today announced that all patients in the ongoing Phase IIa study with FOL-005 for the tr...
BioStock published an article on 30 March 2021 about Follicum, which can be read in full below. Foll...
BioStock published an article on 1 February 2021 about Follicum, which can be read in full below. Fo...
BioStock published an article on 17 December 2020 about Follicum, which can be read in full below. A...
Follicum will attend the BIO International Convention Digital Event on 10-11 & 14-18 June 2021....
Follicum will attend the World Congress for Hair Research in Melbourne (WCHR), Australia, on 22-25 A...
